Clinical-stage biopharmaceutical company
Appears in 1 story · Last updated Oct 21, 2026
Trading on Nasdaq under CTY after its October 2026 IPO closed at $230 million gross
City Therapeutics closed its upsized Nasdaq IPO on October 19, raising $230 million before fees after underwriters bought all 1.67 million extra shares. The Cambridge biotech sold 12.8 million shares at $18 each. Its stock rose about 24% in its October 16 debut.
Updated Oct 21
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
